Top compounds associated with response to FHL5


Feature Type Standardized
Nominal ANOVA
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.077 0.04
mRNA pac-1 CTRPv2 pan-cancer AAC 0.072 0.04
mRNA BX-912 GDSC1000 pan-cancer AAC 0.065 0.04
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.04
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.059 0.04
mRNA Dasatinib FIMM pan-cancer AAC 0.32 0.04
mRNA lenalidomide FIMM pan-cancer AAC 0.33 0.04
mRNA IPA-3 GDSC1000 pan-cancer AAC 0.071 0.04
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.04
mRNA YM201636 GDSC1000 pan-cancer AAC 0.067 0.04
Download CSV